Caesarea-based medical device company Allium Medical Group, developer and manufacturer of anatomically and functionally compatible, dynamic, non-vascular stents, announced today that it has entered into an exclusive distribution agreement with the SynMed International Group for Allium's biliary and ureteral stents. The agreement covers the Swedish and other Scandinavian markets.
Sweden's SynMed Medicinteknik AB is a part of the SynMed International Distributor Network, consisting of several leading European independent distributors of medical diagnostic equipment covering areas of gastroenterology, urology and neurodiagnostics.
SynMed Medicinteknik General Manager Per Gezelius explained, “Our initial agreement with Allium Medical was to distribute the biliary stent in Sweden. The feedback we received from both doctors and patients at medical centers in Stockholm and Helsinki was so strongly positive that we decided to expand our offering to include the ureteral stent, and requested exclusive distribution rights not only for Sweden but for all Scandinavia.”
Founded in 2001, Allium Group has developed site-specific, anatomically and functionally compatible, large caliber dynamic stents for various uses with applications in the urinary and gastro-intestinal tract. Allium completed CE Marking for its biliary and urethral stents, and began distribution of its biliary stents in June 2007 in Italy, Sweden, Germany and Austria. The firm has already received and delivered follow-on orders.
The two different deployment devices of the Allium's biliary stents allow endoscopic (by gastroenterologists) or percutaneous trans-hepatic (by interventional radiologists) insertion. Allium's ureteral stents are mounted on two different deployment devices allowing endoscopic retrograde (by urologists), percutaneous antegrade, or combined antegrade and retrograde insertion.
Allium claims its stents can be removed at any point in time in a short procedure.
"We at Allium are developing a whole new approach to stenting," stated Allium Group president, CSO, and senior consultant (urology) Prof. (Em.) Daniel Yachia, M.D. “Our technology allows us to create site-specific stents so that every organ has an easily removable stent of its own."
Published by Globes [online], Israel business news - www.globes-online.com - on February 12, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008